- Home
- Publications
- Publication Search
- Publication Details
Title
Future Therapeutic Directions for Smac-Mimetics
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 2, Pages 406
Publisher
MDPI AG
Online
2020-02-12
DOI
10.3390/cells9020406
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Immuno-Modulatory Effects of Inhibitor of Apoptosis Protein Antagonists in Cancer Immunotherapy
- (2020) Jessica Michie et al. Cells
- Antagonism of IAPs enhances CAR T cell efficacy
- (2019) Jessica Michie et al. Cancer Immunology Research
- TRADD regulates perinatal development and adulthood survival in mice lacking RIPK1 and RIPK3
- (2019) John P. Dowling et al. Nature Communications
- Redundant and receptor-specific activities of TRADD, RIPK1 and FADD in death receptor signaling
- (2019) Simone Füllsack et al. Cell Death & Disease
- A phase I study of a novel IAP inhibitor APG-1387 as a monotherapy or in combination with pembrolizumab in treatments of patients with advanced solid tumors.
- (2019) Drew W. Rasco et al. JOURNAL OF CLINICAL ONCOLOGY
- Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold
- (2019) David W. Vredevoogd et al. CELL
- BH3 profiling discriminates on-target small molecule BH3 mimetics from putative mimetics
- (2019) Mariana Villalobos-Ortiz et al. CELL DEATH AND DIFFERENTIATION
- Targeting Autophagy in Cancer: Recent Advances and Future Directions
- (2019) Ravi K. Amaravadi et al. Cancer Discovery
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
- (2018) Lorenzo Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Novel smac mimetic APG-1387 elicits ovarian cancer cell killing through TNF-alpha, Ripoptosome and autophagy mediated cell death pathway
- (2018) Bao-Xia Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2
- (2018) Alessandro Annibaldi et al. MOLECULAR CELL
- XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells
- (2018) Jiao Ji et al. Theranostics
- Combination of IAP Antagonists and TNF-α-Armed Oncolytic Viruses Induce Tumor Vascular Shutdown and Tumor Regression
- (2018) Shawn T. Beug et al. Molecular Therapy-Oncolytics
- RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development
- (2018) Holly Anderton et al. CELL DEATH AND DIFFERENTIATION
- Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial
- (2018) Aditya Bardia et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study of a novel IAP inhibitor APG-1387 in patients with advanced solid tumors.
- (2018) Ruihua Xu et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Smac mimetics as novel substrates for p-glycoprotein
- (2018) Manuela Hugle et al. CANCER LETTERS
- DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death
- (2018) Benoît Thibault et al. Scientific Reports
- Inhibitor of Apoptosis Proteins (IAPs) Limit RIPK1-Mediated Skin Inflammation
- (2017) Holly Anderton et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death
- (2017) Isabel Jaco et al. MOLECULAR CELL
- p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection
- (2017) Manoj B. Menon et al. NATURE CELL BIOLOGY
- MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death
- (2017) Yves Dondelinger et al. NATURE CELL BIOLOGY
- Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
- (2017) Shawn T. Beug et al. Nature Communications
- Phase I study evaluating the safety, tolerability, and pharmacokinetics (PK) of HGS1029, a small-molecule inhibitor of apoptosis protein (IAP), in patients (pts) with advanced solid tumors.
- (2017) S. G. Eckhardt et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, pharmacokinetics (PK), and pharmacodynamics (PD) of HGS1029, an inhibitor of apoptosis protein (IAP) inhibitor, in patients (Pts) with advanced solid tumors: Results of a phase I study.
- (2017) B. I. Sikic et al. JOURNAL OF CLINICAL ONCOLOGY
- Reactive oxygen species contribute toward Smac mimetic/temozolomide-induced cell death in glioblastoma cells
- (2016) Mathieu Seyfrid et al. ANTI-CANCER DRUGS
- Necroptosis: an alternative cell death program defending against cancer
- (2016) Dongshi Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis
- (2016) Philippos Perimenis et al. BMC CANCER
- Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics
- (2016) Najoua Lalaoui et al. CANCER CELL
- A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis
- (2016) Ning Li et al. CANCER LETTERS
- SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2
- (2016) Danielle F. Eytan et al. CANCER RESEARCH
- A Phase I Dose-Escalation Study Evaluating the Safety Tolerability and Pharmacokinetics of CUDC-427, a Potent, Oral, Monovalent IAP Antagonist, in Patients with Refractory Solid Tumors
- (2016) A. W. Tolcher et al. CLINICAL CANCER RESEARCH
- LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC
- (2016) Chengcheng Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- IAP antagonists induce anti-tumor immunity in multiple myeloma
- (2016) Marta Chesi et al. NATURE MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia
- (2016) Gabriela Brumatti et al. Science Translational Medicine
- Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL
- (2016) Scott McComb et al. Science Translational Medicine
- Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152
- (2016) A Tchoghandjian et al. Cell Death & Disease
- Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myeloma
- (2016) Vijay Ramakrishnan et al. Oncotarget
- Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer
- (2015) Anne M. Noonan et al. CANCER
- Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study
- (2015) Herbert I. Hurwitz et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Identification of a novel synergistic induction of cell death by Smac mimetic and HDAC inhibitors in acute myeloid leukemia cells
- (2015) Sofie Steinwascher et al. CANCER LETTERS
- cIAP2 supports viability of mice lacking cIAP1 and XIAP
- (2015) K. N. Heard et al. EMBO JOURNAL
- 1977 Synergy of LCL161, an antagonist of inhibitor of apoptosis proteins (IAPs), with paclitaxel in a gene expression signature-enriched cohort of triple-negative breast cancer (TNBC)
- (2015) A. Bardia et al. EUROPEAN JOURNAL OF CANCER
- Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport
- (2015) Randy L. Talbott et al. EXPERIMENTAL CELL RESEARCH
- Small molecule inhibitor of apoptosis proteins antagonists: a patent review
- (2015) Alexander W Hird et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma
- (2015) R. K. Amaravadi et al. MOLECULAR CANCER THERAPEUTICS
- The diverse role of RIP kinases in necroptosis and inflammation
- (2015) John Silke et al. NATURE IMMUNOLOGY
- Reactive oxygen species regulate Smac mimetic/TNFα-induced necroptotic signaling and cell death
- (2015) B Schenk et al. ONCOGENE
- The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma
- (2015) Oscar Matzinger et al. RADIOTHERAPY AND ONCOLOGY
- An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
- (2015) D. M. Janzen et al. Nature Communications
- Systemic use of tumor necrosis factor alpha as an anticancer agent
- (2015) Nicholas J. Roberts et al. Oncotarget
- Smac Mimetic Bypasses Apoptosis Resistance in FADD- or Caspase-8-Deficient Cells by Priming for Tumor Necrosis Factor α-Induced Necroptosis
- (2015) Bram Laukens et al. NEOPLASIA
- Ars Moriendi; the art of dying well - new insights into the molecular pathways of necroptotic cell death
- (2014) J. M. Murphy et al. EMBO REPORTS
- Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors
- (2014) Jeffrey R. Infante et al. JOURNAL OF CLINICAL ONCOLOGY
- Birinapant, a Smac-Mimetic with Improved Tolerability for the Treatment of Solid Tumors and Hematological Malignancies
- (2014) Stephen M. Condon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combination effects of SMAC mimetic birinapant with TNFα, TRAIL, and docetaxel in preclinical models of HNSCC
- (2014) Danielle F. Eytan et al. LARYNGOSCOPE
- Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma
- (2014) V Ramakrishnan et al. LEUKEMIA
- Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF- B Activation, and Is Active in Patient-Derived Xenograft Models
- (2014) C. A. Benetatos et al. MOLECULAR CANCER THERAPEUTICS
- Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3
- (2014) Huayi Wang et al. MOLECULAR CELL
- Smac mimetics and innate immune stimuli synergize to promote tumor death
- (2014) Shawn T Beug et al. NATURE BIOTECHNOLOGY
- IGF2BP1 controls cell death and drug resistance in rhabdomyosarcomas by regulating translation of cIAP1
- (2014) M D Faye et al. ONCOGENE
- X-Linked Inhibitor of Apoptosis Protein – A Critical Death Resistance Regulator and Therapeutic Target for Personalized Cancer Therapy
- (2014) Petra Obexer et al. Frontiers in Oncology
- Physiologically based pharmacokinetic and pharmacodynamic modeling of an antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in a mouse xenograft model of human breast cancer
- (2013) Tao Zhang et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
- (2013) C. Krepler et al. CLINICAL CANCER RESEARCH
- Targeting RNA polymerase I transcription and the nucleolus for cancer therapy
- (2013) Ross D Hannan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
- (2013) James M. Murphy et al. IMMUNITY
- The role of iron and reactive oxygen species in cell death
- (2013) Scott J Dixon et al. Nature Chemical Biology
- Smac mimetic compound LCL161 sensitizes esophageal carcinoma cells to radiotherapy by inhibiting the expression of inhibitor of apoptosis protein
- (2013) Qin Qin et al. TUMOR BIOLOGY
- Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells
- (2012) Kuen-Feng Chen et al. BIOCHEMICAL PHARMACOLOGY
- Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism
- (2012) Jennifer L. Allensworth et al. BREAST CANCER RESEARCH AND TREATMENT
- AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer
- (2012) Melissa K. Brunckhorst et al. CANCER BIOLOGY & THERAPY
- Inhibition of RNA Polymerase I as a Therapeutic Strategy to Promote Cancer-Specific Activation of p53
- (2012) Megan J. Bywater et al. CANCER CELL
- Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity
- (2012) Z Yuan et al. CANCER GENE THERAPY
- IAPs limit activation of RIP kinases by TNF receptor 1 during development
- (2012) Maryline Moulin et al. EMBO JOURNAL
- Inhibitor of Apoptosis Proteins Limit RIP3 Kinase-Dependent Interleukin-1 Activation
- (2012) James E. Vince et al. IMMUNITY
- Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)
- (2012) John A. Flygare et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies
- (2012) S Fulda LEUKEMIA
- XIAP Inhibition and Generation of Reactive Oxygen Species Enhances TRAIL Sensitivity in Inflammatory Breast Cancer Cells
- (2012) J. L. Allensworth et al. MOLECULAR CANCER THERAPEUTICS
- A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell Death
- (2012) Laura S. Dickens et al. MOLECULAR CELL
- Targeting IAP proteins for therapeutic intervention in cancer
- (2012) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2
- (2011) M Darding et al. CELL DEATH AND DIFFERENTIATION
- Smac Mimetics Activate the E3 Ligase Activity of cIAP1 Protein by Promoting RING Domain Dimerization
- (2011) Rebecca Feltham et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment
- (2011) Qian Cai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Linear ubiquitination prevents inflammation and regulates immune signalling
- (2011) Björn Gerlach et al. NATURE
- Initial testing (stage 1) of LCL161, a SMAC mimetic, by the pediatric preclinical testing program
- (2011) Peter J. Houghton et al. PEDIATRIC BLOOD & CANCER
- Antagonists Induce a Conformational Change in cIAP1 That Promotes Autoubiquitination
- (2011) E. C. Dueber et al. SCIENCE
- Asymmetric Recruitment of cIAPs by TRAF2
- (2010) Peter D. Mace et al. JOURNAL OF MOLECULAR BIOLOGY
- Smac mimetics: implications for enhancement of targeted therapies in leukemia
- (2010) E Weisberg et al. LEUKEMIA
- Crystal Structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 Complexes: Affinity, Specificity, and Regulation
- (2010) Chao Zheng et al. MOLECULAR CELL
- Molecular mechanisms of necroptosis: an ordered cellular explosion
- (2010) Peter Vandenabeele et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Antagonism of c-IAP and XIAP Proteins Is Required for Efficient Induction of Cell Death by Small-Molecule IAP Antagonists
- (2009) Chudi Ndubaku et al. ACS Chemical Biology
- Redox Regulation of Tumor Necrosis Factor Signaling
- (2009) Derick Han et al. ANTIOXIDANTS & REDOX SIGNALING
- Different forms of cell death induced by putative BCL2 inhibitors
- (2009) M Vogler et al. CELL DEATH AND DIFFERENTIATION
- Cytoprotective effects of IAPs revealed by a small molecule antagonist
- (2008) Stefanie Galbán et al. BIOCHEMICAL JOURNAL
- Molecular Characterization of the Pediatric Preclinical Testing Panel
- (2008) G. Neale et al. CLINICAL CANCER RESEARCH
- Ubiquitylation and Cancer Development
- (2008) John Silke et al. CURRENT CANCER DRUG TARGETS
- Impact of XIAP protein levels on the survival of myeloma cells
- (2008) G. Desplanques et al. HAEMATOLOGICA
- cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination
- (2008) Mathieu J.M. Bertrand et al. MOLECULAR CELL
- IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-κB as well as cell survival and oncogenesis
- (2008) Mads Gyrd-Hansen et al. NATURE CELL BIOLOGY
- Both cIAP1 and cIAP2 regulate TNF -mediated NF- B activation
- (2008) D. J. Mahoney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now